XBI241129P115000
- 15.78
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Stocks Ride to Best Month in a Year as 'Red Sweep' Unleashes 'Animal Spirits'
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Barclays's 'Bang-for-the-buck' Tail Hedging ETFs: HYG, XLF, IYR
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Wednesday Ends With Index Decline | Wall Street Today
Biotech ETF (XBI) Ended a Diagonal: Looking for Buying Dips
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Sarepta Therapeutics Analyst Ratings
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
(ABBV) - Analyzing AbbVie's Short Interest
How Is The Market Feeling About United Therapeutics?
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"